Article
Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines
14 May 2015
Abstract excerpt
UNLABELLED: Several members of the Arenaviridae family cause hemorrhagic fever disease in humans and pose serious public health problems in their geographic regions of endemicity as well as a credible biodefense threat. To date, there have been no FDA-approved arenavirus vaccines, and current antiarenaviral therapy is limited to an off-label use of ribavirin that is only partially effective. Arenaviruses are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
